share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4：持股变动声明-董事 AFEYAN NOUBAR
美股sec公告 ·  04/19 19:05
Moomoo AI 已提取核心信息
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 17, 2024. The transactions were executed in the open market with prices ranging from $103.0983 to $104.4896 per share, resulting in a total market value of approximately $1,550,703. After the sale, Afeyan directly holds 2,056,931 shares of Moderna. Additionally, Afeyan has an indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 17, 2024. The transactions were executed in the open market with prices ranging from $103.0983 to $104.4896 per share, resulting in a total market value of approximately $1,550,703. After the sale, Afeyan directly holds 2,056,931 shares of Moderna. Additionally, Afeyan has an indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
与 Moderna, Inc. [MRNA] 关联的 Noubar Afeyan 于 2024 年 4 月 17 日完成了 15,000 股普通股的出售。这些交易是在公开市场上执行的，价格从每股103.0983美元到104.4896美元不等，总市值约为1,550,703美元。出售后，Afeyan直接持有Moderna的2,056,931股股份。此外，Afeyan通过旗舰风险投资基金IV、L.P.、旗舰风险投资基金IV-Rx、L.P. 和旗舰先锋公司拥有9,666,038股股票的间接实益所有权。
与 Moderna, Inc. [MRNA] 关联的 Noubar Afeyan 于 2024 年 4 月 17 日完成了 15,000 股普通股的出售。这些交易是在公开市场上执行的，价格从每股103.0983美元到104.4896美元不等，总市值约为1,550,703美元。出售后，Afeyan直接持有Moderna的2,056,931股股份。此外，Afeyan通过旗舰风险投资基金IV、L.P.、旗舰风险投资基金IV-Rx、L.P. 和旗舰先锋公司拥有9,666,038股股票的间接实益所有权。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息